Ratings Arteris, Inc.

Equities

AIP

US04302A1043

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
8.17 ^USD	+1.49%		+0.49%	+38.71%

May. 22	Andes Technology and Arteris, Inc. Partner to Accelerate RISC-V SoC Adoption	CI
May. 02	Arteris, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the past year, analysts have significantly revised downwards their profit estimates.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
ARTERIS, INC.	+38.71%	314M	-
SYNOPSYS INC.	+8.91%	85.92B	B
CADENCE DESIGN SYSTEMS, INC.	+5.14%	77.93B	B+
DASSAULT SYSTÈMES SE	-16.20%	52.89B	B+
PALANTIR TECHNOLOGIES INC.	+26.18%	48.28B	D+
THE TRADE DESK, INC.	+28.93%	45.38B	D+
ATLASSIAN CORPORATION	-34.05%	40.83B	B-
SEA LIMITED	+66.72%	38.78B	D+
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-0.36%	27.48B	C+
ROBLOX CORPORATION	-26.47%	21.52B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes